Literature DB >> 20144365

Maggot therapy takes us back to the future of wound care: new and improved maggot therapy for the 21st century.

Ronald A Sherman1.   

Abstract

In the 21st century, eighty years after William Baer presented his groundbreaking work treating bone and soft tissue infections with live maggots, thousands of therapists around the globe have rediscovered the benefits of maggot therapy. The renaissance in maggot therapy is due in large part to recent technological advancements that have solved or minimized many of the treatment's earlier drawbacks: the need for reliable access to this perishable medical device, simplified application, and low-cost production. Modern dressing materials have simplified the procedure and minimized the risk of escaping maggots. The establishment of dozens of laboratories throughout the world, along with access to overnight courier services in many regions, has made medicinal maggots readily available to millions of people in need. Studies show that fears of patient nonacceptance are unfounded. The medical literature is rapidly growing with scientific evidence demonstrating the efficacy and safety of maggot therapy for a variety of problematic wounds. This article examines how these and other technologies are optimizing the study and application of maggot therapy for wound care. (c) 2009 Diabetes Technology Society.

Entities:  

Mesh:

Year:  2009        PMID: 20144365      PMCID: PMC2771513          DOI: 10.1177/193229680900300215

Source DB:  PubMed          Journal:  J Diabetes Sci Technol        ISSN: 1932-2968


  60 in total

Review 1.  Larval therapy.

Authors:  M Jones; S Thomas
Journal:  Nurs Stand       Date:  2000 Feb 2-8

2.  The current status of maggot therapy in wound healing.

Authors:  S Thomas; M Jones; K Wynn; T Fowler
Journal:  Br J Nurs       Date:  2001-12

3.  Amputation-sparing treatment by nature: "surgical" maggots revisited.

Authors:  G N Jukema; A G Menon; A T Bernards; P Steenvoorde; A Taheri Rastegar; J T van Dissel
Journal:  Clin Infect Dis       Date:  2002-12-02       Impact factor: 9.079

4.  Maggot therapy for treating diabetic foot ulcers unresponsive to conventional therapy.

Authors:  Ronald A Sherman
Journal:  Diabetes Care       Date:  2003-02       Impact factor: 19.112

5.  Maggot therapy for subacute mastoiditis.

Authors:  K L Horn; A H Cobb; G A Gates
Journal:  Arch Otolaryngol       Date:  1976-06

6.  Maggots and wound healing: an investigation of the effects of secretions from Lucilia sericata larvae upon the migration of human dermal fibroblasts over a fibronectin-coated surface.

Authors:  Adele J Horobin; Kevin M Shakesheff; David I Pritchard
Journal:  Wound Repair Regen       Date:  2005 Jul-Aug       Impact factor: 3.617

7.  Promotion of human dermal fibroblast migration, matrix remodelling and modification of fibroblast morphology within a novel 3D model by Lucilia sericata larval secretions.

Authors:  Adele J Horobin; Kevin M Shakesheff; David I Pritchard
Journal:  J Invest Dermatol       Date:  2006-06       Impact factor: 8.551

8.  Clinical and microbiological efficacy of MDT in the treatment of diabetic foot ulcers.

Authors:  T I Tantawi; Y M Gohar; M M Kotb; F M Beshara; M M El-Naggar
Journal:  J Wound Care       Date:  2007-10       Impact factor: 2.072

9.  Maggot therapy for treating pressure ulcers in spinal cord injury patients.

Authors:  R A Sherman; F Wyle; M Vulpe
Journal:  J Spinal Cord Med       Date:  1995-04       Impact factor: 1.985

10.  Biosurgery supports granulation and debridement in chronic wounds--clinical data and remittance spectroscopy measurement.

Authors:  Uwe Wollina; Kristin Liebold; Wolf-Dieter Schmidt; Michael Hartmann; Dieter Fassler
Journal:  Int J Dermatol       Date:  2002-10       Impact factor: 2.736

View more
  32 in total

1.  Maggot debridement therapy in the treatment of complex diabetic wounds.

Authors:  Michelle L Marineau; Mark T Herrington; Karen M Swenor; Lawrence J Eron
Journal:  Hawaii Med J       Date:  2011-06

2.  [Poorly healing periorbital wounds. Therapeutic use of maggots].

Authors:  S Pitz; G Renieri; A Gericke
Journal:  Ophthalmologe       Date:  2012-05       Impact factor: 1.059

Review 3.  [Biosurgical débridement using Lucilia sericata-maggots - an update].

Authors:  Pietro Nenoff; Antonia Herrmann; Christina Gerlach; Jürgen Herrmann; Jan Christoph Simon
Journal:  Wien Med Wochenschr       Date:  2010-08-16

4.  Histological patterns in healing chronic wounds using Cochliomyia macellaria (Diptera: Calliphoridae) larvae and other therapeutic measures.

Authors:  Franciéle Souza de Masiero; Mariana Prado Nassu; Mauro Pereira Soares; Patricia Jacqueline Thyssen
Journal:  Parasitol Res       Date:  2015-04-24       Impact factor: 2.289

Review 5.  Literature review on the management of diabetic foot ulcer.

Authors:  Leila Yazdanpanah; Morteza Nasiri; Sara Adarvishi
Journal:  World J Diabetes       Date:  2015-02-15

6.  Survey of patients of the Tver region of Russia regarding maggots and maggot therapy.

Authors:  Artem M Morozov; Ronald A Sherman
Journal:  Int Wound J       Date:  2018-12-13       Impact factor: 3.315

7.  First Record of Larval Secretions of Cochliomyia macellaria (Fabricius, 1775) (Diptera: Calliphoridae) Inhibiting the Growth of Staphylococcus aureus and Pseudomonas aeruginosa.

Authors:  F S Masiero; M F K Aquino; M P Nassu; D I B Pereira; D S Leite; P J Thyssen
Journal:  Neotrop Entomol       Date:  2016-10-01       Impact factor: 1.434

8.  Myiasis in humans-a global case report evaluation and literature analysis.

Authors:  Victoria Bernhardt; Fabian Finkelmeier; Marcel A Verhoff; Jens Amendt
Journal:  Parasitol Res       Date:  2018-11-19       Impact factor: 2.289

Review 9.  Traditional Therapies for Skin Wound Healing.

Authors:  Rúben F Pereira; Paulo J Bártolo
Journal:  Adv Wound Care (New Rochelle)       Date:  2016-05-01       Impact factor: 4.730

10.  Warfarin-induced skin necrosis diagnosed on clinical grounds and treated with maggot debridement therapy.

Authors:  Anna Louise Biscoe; Alison Bedlow
Journal:  BMJ Case Rep       Date:  2013-01-28
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.